tiprankstipranks
pc:epsil

Epsilogen

A biotech leader focused on developing immunoglobulin E (IgE) antibodies for cancer therapy.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$16M
Total Amount Raised$16M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$16M
Latest Funding Amount$16M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Nov 19, 2025
Investment
$16.40M

Investors

Investor Name
Funding Round

Related News and Analysis